Stocks in focus: Reata Pharmaceuticals stock soars after FDA-drug approval; Novavax falls after vaccine maker issues ‘substantial doubts’ over future operations
March 01, 2023 at 07:33 AM EST
Here are U.S. stocks in focus ahead of Wednesday’s trading session.
